The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of combination strategies for focal adhesion kinase inhibition in diffuse gastric cancer.
 
Ke Peng
No Relationships to Disclose
 
Adam Joel Bass
Leadership - Earli; Helix Nanotechnologies; Signet Therapeutics
Stock and Other Ownership Interests - Earli; Helix Nanotechnologies; Signet Therapeutics
Consulting or Advisory Role - Roche; Silverback Therapeutics
Research Funding - Bayer; Novartis; Repare Therapeutics
Travel, Accommodations, Expenses - Lilly